Follow up of a HNF-1alpha mutant carrier with a severely impaired beta cell function.
Costa
A
A
Rodriguez
C
C
Gomis
R
R
Conget
I
I
Casamitjana
R
R
Bescos
M
M
D000328:Adult; D019943:Amino Acid Substitution; D015992:Body Mass Index; D004268:DNA-Binding Proteins / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics* / Q000503:physiopathology*; D005500:Follow-Up Studies; D006580:Genetic Carrier Screening; D005951:Glucose Tolerance Test; D051537:Hepatocyte Nuclear Factor 1; D051538:Hepatocyte Nuclear Factor 1-alpha; D051539:Hepatocyte Nuclear Factor 1-beta; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000503:physiopathology*; D008297:Male; D009687:Nuclear Proteins; D010375:Pedigree; D017354:Point Mutation; D013997:Time Factors; D014157:Transcription Factors / Q000235:genetics*
D004268:DNA-Binding Proteins; C496487:HNF1A protein, human; C496495:HNF1B protein, human; D051538:Hepatocyte Nuclear Factor 1-alpha; D007328:Insulin; D009687:Nuclear Proteins; D014157:Transcription Factors; D051537:Hepatocyte Nuclear Factor 1; D051539:Hepatocyte Nuclear Factor 1-beta